Skip to main content
Signal8
Brottem John L. profile photo

John L. Brottem

CIK: 0001823381

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)16 (80.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (20.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Alamar Biosciences, Inc. logo
ALMR

Alamar Biosciences, Inc.

Officer
Outset Medical, Inc. logo
OM

Outset Medical, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (20 total)

  • Alamar Biosciences, Inc. logo
    ALMR

    Alamar Biosciences, Inc.

    Sep 14, 2026
    Award(A)
    Direct
    29K shares-
  • Outset Medical, Inc. logo
    OM

    Outset Medical, Inc.

    Aug 17, 2026
    Sale(S)
    Direct
    2.6K shares at avg. $4.39$12K
  • Outset Medical, Inc. logo
    OM

    Outset Medical, Inc.

    Jun 26, 2026
    Award(A)
    Direct
    59.8K shares-
  • Outset Medical, Inc. logo
    OM

    Outset Medical, Inc.

    May 15, 2026
    Sale(S)
    Direct
    2.6K shares at avg. $3.70$10K
  • Outset Medical, Inc. logo
    OM

    Outset Medical, Inc.

    Feb 17, 2026
    Sale(S)
    Direct
    2.8K shares at avg. $3.35$10K
  • Outset Medical, Inc. logo
    OM

    Outset Medical, Inc.

    Jan 21, 2026
    Sale(S)
    Direct
    1.2K shares at avg. $5.01$6K
  • Outset Medical, Inc. logo
    OM

    Outset Medical, Inc.

    Jan 20, 2026
    Sale(S)
    Direct
    9.3K shares at avg. $5.12$48K
  • Outset Medical, Inc. logo
    OM

    Outset Medical, Inc.

    Jan 7, 2026
    Sale(S)
    Direct
    224 shares at avg. $4.27$956.48
  • Outset Medical, Inc. logo
    OM

    Outset Medical, Inc.

    Nov 17, 2025
    Sale(S)
    Direct
    388 shares at avg. $4.60$2K
  • Outset Medical, Inc. logo
    OM

    Outset Medical, Inc.

    Aug 15, 2025
    Sale(S)
    Direct
    383 shares at avg. $12.88$5K
  • Outset Medical, Inc. logo
    OM

    Outset Medical, Inc.

    Jun 10, 2025
    Award(A)
    Direct
    36K shares-
  • Outset Medical, Inc. logo
    OM

    Outset Medical, Inc.

    May 15, 2025
    Sale(S)
    Direct
    396 shares at avg. $17.82$7K
  • Outset Medical, Inc. logo
    OM

    Outset Medical, Inc.

    Feb 18, 2025
    Sale(S)
    Direct
    6.1K shares at avg. $0.90$6K
  • Outset Medical, Inc. logo
    OM

    Outset Medical, Inc.

    Jan 21, 2025
    Sale(S)
    Direct
    2.7K shares at avg. $0.80$2K
  • Outset Medical, Inc. logo
    OM

    Outset Medical, Inc.

    Jan 21, 2025
    Sale(S)
    Direct
    29.5K shares at avg. $0.80$24K
  • Outset Medical, Inc. logo
    OM

    Outset Medical, Inc.

    Jan 21, 2025
    Sale(S)
    Direct
    777 shares at avg. $0.80$621.6
  • Outset Medical, Inc. logo
    OM

    Outset Medical, Inc.

    Jan 17, 2025
    Award(A)
    Direct
    9.1K shares-
  • Outset Medical, Inc. logo
    OM

    Outset Medical, Inc.

    Jan 13, 2025
    Sale(S)
    Direct
    20.5K shares at avg. $0.81$17K
  • Outset Medical, Inc. logo
    OM

    Outset Medical, Inc.

    Jan 7, 2025
    Sale(S)
    Direct
    1.6K shares at avg. $1.29$2K
  • Outset Medical, Inc. logo
    OM

    Outset Medical, Inc.

    Nov 15, 2024
    Sale(S)
    Direct
    3.2K shares at avg. $0.80$3K

1-20 of 20

About Brottem John L.

Brottem John L. (SEC CIK 0001823381) files insider reports with the SEC as General Counsel of Alamar Biosciences, Inc. (ALMR) and General Counsel of Outset Medical, Inc. (OM).

Signal8 holds 17 ownership filings by Brottem John L. (1 Form 3, 16 Form 4), filed between Nov 18, 2024 and Sep 16, 2026. Those filings report 20 transactions, from Nov 15, 2024 to Sep 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Brottem John L.'s filings is in FREMONT, CA.

Recent filings by Brottem John L.

  • Sep 14, 2026: Grant or award of ALMR shares (Form 4, code A).
  • Aug 17, 2026: Open-market sale of OM shares (Form 4, code S).
  • Jun 26, 2026: Grant or award of OM shares (Form 4, code A).
  • May 15, 2026: Open-market sale of OM shares (Form 4, code S).
  • Feb 17, 2026: Open-market sale of OM shares (Form 4, code S).

Other insiders filing for Alamar Biosciences, Inc. (ALMR)

How to read Form 4 transaction codes